• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Flexible light-based system gets FDA nod

TheraLight received clearance from the U.S. Food and Drug Administrationto market its UV120-2 UVA/UUVB Phototherapy System for the treatment ofpsoriasis, vitiligo, atopic dermatitis and seborrheic dermatitis.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
Related Content
Ethanol-Based Hand Sanitizer Shows No Visible Dermal Toxicity; Further Testing Warranted
July 11th 2025

Ethanol-Based Hand Sanitizer Shows No Visible Dermal Toxicity; Further Testing Warranted

Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness
May 23rd 2025

Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness

Scalp Disorders in SoC: A Diagnostic Blind Spot
July 11th 2025

Scalp Disorders in SoC: A Diagnostic Blind Spot

Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
May 20th 2025

Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor

FDA News and Decisions: Midyear Updates
July 11th 2025

FDA News and Decisions: Midyear Updates

Daily Derm Times: July 10, 2025
July 11th 2025

Daily Derm Times: July 10, 2025

© 2025 MJH Life Sciences

All rights reserved.